IP Library Granted Patent US 12,582,149
Granted Patent B1
US 12,582,149 · App. 19/289,077 · Granted Mar 24, 2026

Functional additive for hot beverages and foods

Inventor: Igor Miljkovic (Palm Desert, CA)
A23L33/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,582,149
App. No.
19/289,077
Granted
Mar 24, 2026
Kind
B1
Abstract

The present disclosure provides functional compositions for producing hydrogen in hot foods and beverages. In certain embodiments a composition for a functional powder additive containing unstabilized elemental zinc and a chelated mineral salt is described. Certain embodiments include a quantity of unstabilized elemental zinc having a particle size of 37 μm and a molar excess of the chelated mineral salt potassium citrate packaged in small sachets which are intended to be added directly to hot coffee and/or hot tea beverages having at least a temperature of 168° F.

Claims (8)

1 . A composition for use as a functional additive in hot foods and beverages, said composition comprising:

5 to 35 mg of unstabilized elemental zinc, wherein the unstabilized elemental zinc is zero-valent, non-ionic, and non-oxidized, has a particle size ranging from 25 μm to 75 μm, and has a purity of at least 98%; and

a chelated mineral salt wherein, upon contact with an aqueous medium having a temperature of at least 168° F., the composition reacts with water to produce hydrogen gas.

2 . The composition of claim 1 , wherein the unstabilized elemental zinc has a morphology selected from a group consisting of: flaked, granular, crushed, amorphous, spherical, and any combination thereof.

3 . The composition of claim 1 wherein the chelated mineral salt is selected from the group consisting of: potassium gluconate, potassium citrate, potassium tartrate, potassium lactate, potassium aspartate, magnesium citrate, magnesium gluconate, magnesium lactate, magnesium aspartate, magnesium glycinate, magnesium malate, magnesium tartrate, zinc gluconate, zinc picolinate, zinc citrate, zinc bisglycinate, zinc aspartate, calcium gluconate, calcium citrate, calcium lactate, calcium aspartate, sodium citrate, sodium gluconate, sodium lactate, sodium tartrate, and any combination thereof.

4 . The composition of claim 1 wherein the chelated mineral salt is in molar excess of the unstabilized elemental zinc.

5 . The composition of claim 1 further comprising between 5 mg to 10 mg of copper glycinate.

6 . The composition of claim 5 , wherein the composition is in the form of a mini-caplet and further comprises a filler, tableting lubricant and a binder.

References Cited (14)
US 5612061A · Rabkin · 1997 [cited by applicant]
US 8852660B2 · Miljkovic · 2014 [cited by applicant]
US 9144581B2 · Miljkovic · 2015 [cited by applicant]
US 9539282B2 · Lucas · 2017 [cited by applicant]
US 11266169B2 · Tarnava · 2022 [cited by applicant]
US 20160113865A1 · Kazakevitch · 2016 [cited by applicant]
JP 2015205791A · 2015 [cited by applicant]
WO WO2025064685A1 · 2025 [cited by examiner]
Ohta, Shigeo, Chapter Fifteen—Molecular Hydrogen as a Novel Antioxidant: Overview of the Advantages of Hydrogen for Medical Applications, Methods in Enzymology, vol. S55, pp. 289-317, 2015. [cited by applicant]
Ichihara, M. et al, Beneficial biological effects and the underlying mechanisms of molecular hydrogen—comprehensive review of 321 original articles, Medical Gas Research, vol. 5, Article 12, 2015. [cited by applicant]
Ohta, Shigeo, Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine, Pharmacology & Therapeutics, vol. 144, Issue I, pp. 1-11, 2015. [cited by applicant]
Ge, Li et al, Molecular hydrogen: a preventive and therapeutic medical gas for various diseases, Oncotarget, 2017; 8: 102653-102673. [cited by applicant]
Ohno, K. et al, Molecular Hydrogen as an Emerging Therapeutic Medical Gas for Neurodegenerative and Other Diseases, Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 353152. [cited by applicant]
Lebaron, T.W. et al, ORP should not be used to estimate or compare concentrations of aqueous H2: An in silico analysis and narrative synopsis, Frontiers in Food Science and Technology, 2:1007001, 2022. [cited by applicant]